GT
Graham S. Taylor

Elite Scholar

117
Works
17,023
Citations
39
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Graham S. Taylor

Also known as: G. S. Taylor, G. Taylor, GS Taylor, Graham S Taylor, Graham S. Taylor

117

Total Works

17,023

Citations

39

H-Index

66

i10-Index

Citation & Works Trend by Year
27 years active
Top Research Topics
Viral-associated cancers and disorders (59) Immunotherapy and Immune Responses (41) T-cell and B-cell Immunology (25) Cytomegalovirus and herpesvirus research (25) Herpesvirus Infections and Treatments (17)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Loss of systemic anti-viral immunity and LMP1-driven suppressive myeloid tumour niches converge to shape the immunobiology of Epstein-Barr virus-positive diffuse large B-cell lymphoma Leukemia 0
2025 Lupus may be triggered by a common virus – new research 0
2025 The spatial landscape of infectious mononucleosis tonsils bioRxiv (Cold Spring Harbor Laboratory) 3
2025 CellMAPS: A no-code model-based customisable multiplex image analysis workflow bioRxiv (Cold Spring Harbor Laboratory) 3
2025 Multi-omic spatial profiling reveals the unique SARS-CoV-2 lung microenvironment and collagen VI as a predictive biomarker in severe COVID-19 European Respiratory Journal 5
2024 Defects in NK cell immunity of pediatric cancer patients revealed by deep immune profiling iScience 3
2024 Hodgkin/Reed-Sternberg cells induce GPNMB expression and release from macrophages to suppress T-cell responses to the Epstein-Barr virus-encoded LMP2A protein Haematologica 1
2024 Epstein-Barr virus: how does a common infection trick the immune system into attacking the brain in people with MS? 0
2024 Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis PLoS Pathogens 24
2024 Enhanced CD95 and interleukin 18 signalling accompany T cell receptor Vβ21.3+ activation in multi-inflammatory syndrome in children Nature Communications 7
2024 Bioengineered small extracellular vesicles deliver multiple SARS‐CoV‐2 antigenic fragments and drive a broad immunological response Journal of Extracellular Vesicles 6
2023 Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping British Journal of Cancer 22
2023 Multi-omic spatial profiling in COVID-19 lung revels temporal evolution of the disease and novel collagen VI biomarker for outcome The Journal of Immunology 0
2023 Supplementary Methods, Figures 1 - 3, Tables 1 - 2 from A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer 0
2023 Data from A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer 0

Data source: OpenAlex API